Genai At | Manulife ^new^

GenAI is not a science project for Manulife; it is a competitive necessity. Rivals (e.g., John Hancock, Sun Life, Ping An) are already deploying similar capabilities. However, Manulife’s advantage lies in its global scale and conservative risk culture.

Manulife has been actively exploring the potential of GenAI to drive business value across various aspects of its operations. The company has established a dedicated team to focus on GenAI research and development, collaborating with leading technology partners and academic institutions to stay at the forefront of this rapidly evolving field. genai at manulife

This strategic shift is backed by a multi-billion-dollar digital investment and a roadmap designed to generate over by 2027. Core GenAI Strategic Pillars GenAI is not a science project for Manulife;

To ensure security and compliance, Manulife should deploy a : Manulife has been actively exploring the potential of

The adoption of GenAI at Manulife has the potential to drive significant benefits across various aspects of the business. Some of the key advantages include: